International Myeloma Society

The International Myeloma Society (IMS) is a global organization dedicated to advancing research, education, and patient care for multiple myeloma, a type of blood cancer affecting plasma cells in the bone marrow. It brings together healthcare professionals, researchers, and patients to share knowledge, develop new treatments, and improve outcomes. By fostering collaboration across countries, the IMS aims to accelerate progress in understanding and managing the disease, ultimately working toward better survival rates and quality of life for those affected.